DelveInsight’s, “Non-Hodgkin Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Non-Hodgkin Lymphoma pipeline landscape.

Dave Coulier recalled the moment he got diagnosed with cancer, his immunity problems after chemotherapy, and the beacons of ...

Brauninger, A, Hansmann, M-L, Strickler, JG, et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med ...

Roche has demonstrated the power of combining two of oncology’s hottest modalities—bispecifics and antibody-drug conjugates ...

The story of the birth and growth of nuclear science is rebalanced in Destroyer of Worlds, which gives due prominence to the ...

The FDA has approved Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free ...

As it prepares to present the latest data from the phase I/II clinical trial of EO-2463, Enterome SA has secured $19 million to expand and complete the study, and to scope phase III development of the ...

Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and ...

Dave Coulier has been candid about his cancer battle and recovery in 2025 with support from wife Melissa and 'Full House' star Candace Cameron Bure ...